Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
| Brand name | IBUPROFEN |
| Generic name | IBUPROFEN |
| Active ingredient(s) | IBUPROFEN |
| Distributed by / for | Drug Mart, Food Fair, Medina, Ohio 44256 |
| NDC | 53943-291-15 |
| Full product label | Ibuprofen Tablets, USP, 200 mg, a) 50 tablet (NDC 53943-291-15), b) 100 tablet (NDC 53943-291-12), c) 500 tablet (NDC 53943-291-14), Brown, Distributed by Drug Mart, Food Fair, Medina, Ohio 44256 |
| Recalling firm | Time-Cap Laboratories, Inc. |
| Distribution | Nationwide. |
| Quantity | N/A |
| Recall initiated | 2018-01-11 |
| Report date | 2018-05-02 |
| Recall completed | 2021-01-20 |
| Recall number | D-0686-2018 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Farmingdale NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗